ArticleMedicine2025
Trends and levels of the global, regional, and national burden of vascular intestinal disorders between 1990 and 2021: Findings from the global burden of disease study 2021.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vascular Intestinal Disorder (VID) significantly impacts the global disease burden, with notable regional variations in incidence, prevalence, and Disability-Adjusted Life-Years (DALYs). While high-income countries have seen a decline in VID burden due to improved healthcare, lower-income regions continue to face rising VID rates. Understanding these trends is essential for developing effective health policies and interventions. This study aimed to analyze the global trends in VID incidence, prevalence, and DALYs from 1990 to 2021. We utilized data from the global burden of disease study to calculate age-standardized rates for incidence, prevalence, and DALYs of VID from 1990 to 2021. Joinpoint regression analysis was performed to assess trend changes over time. An age-period-cohort analysis explored the impact of age, period, and birth cohort on VID burden. Decomposition, inequality, and frontier analyses were conducted to investigate the contributions of aging, population growth, and epidemiological changes to the VID burden. Overall, the global trends of VID incidence, prevalence, and DALYs showed a decline over the past 3 decades. However, regional disparities were evident. High and upper-middle socio-demographic index (SDI) regions saw significant declines in both incidence and prevalence, while low and lower-middle SDI regions experienced increases. DALYs showed a decreasing trend in most regions, though certain areas, including Central Asia and Eastern Europe, demonstrated increases. The age-period-cohort analysis revealed that age is a significant determinant of VID burden, with incidence, prevalence, and DALYs increasing with age. Population growth and aging were found to be the main drivers of increased VID burden, while epidemiological changes contributed to a global reduction in VID burden. Inequality analysis showed persistent disparities, with low-SDI regions bearing a disproportionate share of the VID burden. Policymakers must focus on addressing health inequalities and ensuring equitable distribution of global health interventions. Future research should investigate the specific causes and subtypes of VID, and improve global health data monitoring to better predict and manage shifts in disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.